Rome, Nov 6. (Adnkronos Health) – The Cnel Participation Commission “works on collective agreements and contracts signed with trade union counterparts as required by law 76/2025. In Roche’s case, we observed a good economic-financial practice, such as the share ownership plan for all employees, some good organizational practices, I’m referring to the joint Diversity & Inclusion commissions, equal opportunities, and some organizational roles entrusted to employees, and a good consultative practice given by the constant consultation with trade union counterparts. Due to the fact that Roche is a company that has understood the participatory paradigm, it has been awarded the so-called Cnel participation seal.” This was stated by Emmanuele Massagli, president of the Cnel Participation Commission, in Rome, during the meeting ‘The Impact of Roche and the Value of Biotech: the sector as a driver of development and growth for Italy’.
The awarding of the ‘Cnel Seal’ places the company among the excellent realities for inclusion and social dialogue dynamics, a value that also emerged within the second edition of the Roche Impact Study in Italy, carried out with the methodological support of PwC Italy and presented during the Roman conference.